Guest Editors
Dr. Ajit Prakash
Email: ajit@ad.unc.edu
Affiliation: Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Homepage:
Research Interests: Drug Discovery, Biochemistry, Cancer biology, Molecular Biology, GPCR
Dr. Mohammad Ashhar Iqbal Khan
Email: ashharkh@email.unc.edu
Affiliation: Department of Biochemistry & Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.
Homepage:
Research Interests: Protein Biochemistry, Structure Biology, Molecular and Cell Biology, Cell mechanobiology, cell adhesion proteins
Dr. Tara Chand Yadav
Email: tcyadav@unc.edu
Affiliation: Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, 27599, United States.
Homepage:
Research Interests: Structure-Based Drug Designing, Drug Delivery System, Preclinical model development
Summary
Cancer therapy has made significant advancements by targeting well-established cancer drug targets like some kinases and hormone receptors. In recent times, many new drug targets for cancer have emerged. Since there are several parallel mechanisms for cancer development, it's very much needed to uncover more such mechanisms and identify unidentified drug targets. Revealing novel molecular targets for cancer will pave the path for the development of next-generation therapies.
This special issue will explore both well-characterized and emerging drug targets in cancer, delving into their mechanisms of action, strategies for therapeutic targeting, and the latest breakthroughs in drug development. By presenting the current state of knowledge and identifying future directions, the issue aims to guide researchers, clinicians, and drug developers in their efforts to improve cancer treatment outcomes.
Keywords
Cancer drug discovery, drug target
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue